Health ministry decides against including Itolizumab in clinical management protocols for COVID-19

PTI, Jul 26, 2020, 9:17 PM IST


New Delhi: The National Task Force on COVID-19 has decided against including Itolizumab drug in clinical management protocols for treating the disease even though the DCGI has approved its “restricted emergency use” in infected patients, official sources said.

Considering the unmet medical needs in COVID-19, Itolizumab, an already approved drug of Biocon, used for treating psoriasis — a skin condition — was approved for “restricted emergency use” in the treatment of coronavirus by the Drugs Controller General of India (DCGI) recently.

The permission to market the drug was granted for the treatment of cytokine release syndrome in ”moderate” to ”severe” Acute Respiratory Distress Syndrome patients due to COVID-19.

“The issue of including the drug in the clinical protocols was discussed in a meeting held on Friday. A majority of the members of the task force opined that there was not enough evidence currently to get the drug included in the clinical management protocols for COVID-19,” said an official source.

A domestic biopharmaceutical company, Biocon, has been manufacturing and marketing Itolizumab, a monoclonal antibody, for the treatment of patients with moderate to severe chronic plaque psoriasis since 2013, under the brand name ALZUMAb, the Union health ministry had earlier said.

However, a Biocon spokesperson said, “The National Covid Task Force needs to see more evidence and we will provide them large real-world data to enable the committee to reconsider its decision on inclusion of Itolizumab in the protocol.”

“Nearly 1,000 patients have used the drug across the country with good outcome data,” the company spokesperson said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

2 detained for killing tailor in Rajasthan’s Udaipur

Stinking toilets on trains: Railways deploys senior officials for inspection

Taapsee Pannu on teaming up with SRK in ‘Dunki’: It’s a golden opportunity

Eoin Morgan retires, draws curtains on glorious international career

Udupi: Youth enacts kidnap drama to extort Rs 5 Lakhs; ends up behind bars

Tailor murdered over ‘insult to Islam’, tension in Udaipur

No hike in electricity tariff for consumers for now: Min Sunil Kumar issues clarification

Related Articles More

‘Action to be taken against those violating mask rule’

Technical glitch hits compiling of Covid-19 data base for 2nd day

858 COVID-19 cases, 1 death in Karnataka

Mandaviya to chair crucial meeting with experts on rising COVID-19 cases

Karnataka reports 623 COVID-19 cases, 1 death


Bride breaks down after receiving wax statue of her late father as a gift. Video divides Internet

House Caught Fire at Kumta

Major Road Mishap at Hunasur, 1 killed and 4 injured

Vijayapura And Dotihal Tradition : farmers Celebrating Amavasya

Khadar speaks about developmental activities

Latest Additions

Zubair’s ‘objectionable’ tweet of 2018 led to Twitter storm with ‘hate’ speeches: Delhi Police

2 detained for killing tailor in Rajasthan’s Udaipur

Maha CM Thackeray chairs cabinet meeting, first after taking away rebel ministers’ portfolios

Stinking toilets on trains: Railways deploys senior officials for inspection

Taapsee Pannu on teaming up with SRK in ‘Dunki’: It’s a golden opportunity

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.